Large-scale testing (Phase 3)Study completedNCT02152605
What this trial is testing
A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 498